Skip to main
22 Followers • 118 Following

Jj

@jkr69
  1. Asset
    Price
  2. CLNN
    Clene Nanomedicine
  3. Nuwellis
  4. 1847 Holdings LLC
  5. A2Z Smart Technologies Corp
  6. ABVC BioPharma
  7. AEye
  8. AIM ImmunoTech Inc
  9. AMTD Digital
  10. AMTD International Inc
  11. ASP Isotopes Inc
  12. AYRO
  13. Acasti Pharma
  14. Accelerate Diagnostics
  15. Achilles Therapeutics PLC
  16. Aclarion Inc
  17. Acorda Therapeutics
  18. Actelis Networks Inc
  19. Adagene
  20. Adamas One Corp
  21. Addex Therapeutics
  22. Adial Pharmaceuticals Inc
  23. Aethlon Medical
  24. Agenus
  25. Agrify
  26. Aileron Therapeutics
  27. Ainos Inc
  28. Akanda Corp
  29. Akari Therapeutics
  30. Akebia Therapeutics
  31. Akoustis Technologies
  32. Alfi Inc
  33. Alignment Healthcare
  34. Alkaline Water Company Inc (The)
  35. Allarity Therapeutics
  36. Alpine 4 Holdings
  37. Alset EHome International
  38. Alzamend Neuro
  39. Amarin Corporation Plc
  40. American Lithium Corp
  41. American Rebel Holdings Inc
  42. Amesite Operating
  43. Ampio Pharmaceuticals Inc
  44. Amprius Technologies Inc
  45. Amyris Inc
  46. Applied UV
  47. Appreciate Holdings Inc
  48. Aprea Therapeutics
  49. Aptevo Therapeutics
  50. Aptose Biosciences
  51. Aqua Metals
  52. Aquestive Therapeutics Inc
  53. Arcadia Biosciences
  54. Ardelyx
  55. Aridis Pharmaceuticals
  56. Artelo Biosciences Inc
  57. Asensus Surgical
  58. Assertio Therapeutics Inc
  59. Astrotech
  60. Athersys Inc
  61. Atossa Genetics
  62. Atour Lifestyle Holdings Ltd
  63. Augmedix
  64. Ault Alliance Inc
  65. Aurora Cannabis
  66. Austin Gold Corp
  67. Avalo Therapeutics
  68. Avalon GloboCare Corp
  69. Avino Silver & Gold Mines
  70. Aytu BioScience
  71. BIOLASE
  72. BIT Mining Limited
  73. BYND Cannasoft Enterprises Inc
  74. Barrick Gold
  75. Baudax Bio Inc
  76. Better Home & Finance Holding Co
  77. Bio-Path Holdings
  78. BioAtla, Inc
  79. Biodesix
  80. Bioline RX
  81. Bionano Genomics
  82. Biophytis S.A
  83. Biosig Technologies Inc
  84. Biotricity
  85. Bird Global Inc
  86. Bitcoin Depot Inc
  87. Bitfarms Ltd
  88. Bitwise Crypto Innovators ETF
  89. Black Rifle Coffee
  90. Blackboxstocks
  91. Blade Air Mobility
  92. Blue Star Foods Corp
  93. Bluejay Diagnostics
  94. Bone Biologics Corp
  95. Boxlight
  96. Brainstorm Cell Therapeutics
  97. Bright Green Corp
  98. Bright Minds Biosciences
  99. Bruush Oral Care Inc
  100. Butterfly Network
  101. CS Disco
  102. CXApp Inc
  103. CYNGN
  104. Caesars Entertainment
  105. Camber Energy
  106. Can-Fite BioPharma Ltd.
  107. Canoo
  108. Cardiff Oncology
  109. Cardio Diagnostics Holdings In
  110. Carisma Therapeutics Inc
  111. Castellum Inc
  112. Cellectar BioSciences
  113. Celularity
  114. Cemtrex
  115. Cenntro Inc
  116. Cepton
  117. Cerberus Cyber Sentinel Corp
  118. Checkpoint Therapeutics
  119. Chimerix
  120. China Pharma Holdings
  121. Cidara Therapeutics
  122. Cineverse Corp
  123. Cingulate
  124. Citius Pharmaceuticals
  125. CleanSpark
  126. ClearOne
  127. Clearmind Medicine Inc
  128. Clearsign Combustion
  129. Clever Leaves Holdings
  130. Cloopen Group Holding Limited
  131. Clover Health Investments
  132. Coffee Holding
  133. CohBar
  134. Coinbase
  135. ComSovereign Holding
  136. Comera Life Sciences Holdings Inc
  137. Connect Biopharma Holdings
  138. ContraFect Corp
  139. Corbus Pharmaceuticals Holdings
  140. Core Scientific Inc
  141. Core Scientific, Inc.
  142. Core Scientific, Inc.
  143. Corvus Pharmaceuticals
  144. Cosmos Holdings
  145. Courtside Group Inc
  146. Creative Medical Technology Holdings
  147. Crown ElectroKinetics
  148. Cue Biopharma
  149. Cuentas
  150. Cybin
  151. Cyclacel Pharmaceuticals
  152. Cyclo Therapeutics, Inc.
  153. DMK Pharmaceuticals Corp
  154. Dare Bioscience
  155. Dave
  156. Dermata Therapeutics
  157. Desktop Metal
  158. Digital Ally Inc
  159. Digital Brands Group Inc
  160. Disney
  161. Document Security Systems
  162. Dragonfly Energy Holdings Corp
  163. ESS Tech
  164. Eastside Distilling
  165. Eightco Holdings Inc
  166. Electra Battery Materials Corp
  167. ElectroCore Inc
  168. Elicio Therapeutics Inc
  169. Enservco
  170. Ensysce Biosciences
  171. Enzo Biochem
  172. Eos Energy Enterprises
  173. Esports Entertainment Group
  174. Esports Technologies
  175. Evofem Biosciences Inc
  176. Exela Technologies
  177. EyePoint Pharmaceuticals
  178. FOXO Technologies Inc.
  179. Finch Therapeutics Group
  180. First Republic Bank
  181. First Wave BioPharma
  182. FiscalNote Holdings Inc
  183. FlexShopper
  184. Flora Growth Corp
  185. Fluent Inc
  186. Forge Global Holdings Inc
  187. Fresh2 Group Ltd
  188. Freshworks
  189. FuboTV
  190. Fuel Tech
  191. Future FinTech Group
  192. GRI Bio Inc
  193. GSI Technology
  194. Galera Therapeutics
  195. Gelesis Holdings Inc
  196. Genetic Technologies
  197. Geovax Labs
  198. Getaround Inc
  199. Getty Images Holdings Inc
  200. Gevo
  201. Ginkgo Bioworks Holdings
  202. Global X Blockchain ETF
  203. Global X Lithium & Battery Tech ETF
  204. Global X S&P 500 Tail Risk ETF
  205. Globalstar
  206. GlucoTrack Inc
  207. GlycoMimetics
  208. Gold Resource
  209. Golden Minerals Company
  210. Gran Tierra Energy
  211. Granite Ridge Resources Inc
  212. Greenbrook TMS Inc
  213. Greenidge Generation Holdings
  214. Greenlane Holdings
  215. Grindr Inc
  216. Grom Social Enterprises
  217. Grove Collaborative Holdings
  218. Gryphon Digital Mining Inc
  219. Guardion Health Sciences Inc
  220. HTG Molecular Diagnostics Inc
  221. Hall of Fame Resort & Entertainment
  222. Heartcore Enterprises
  223. Heliogen
  224. Helius Medical Technologies
  225. Hempacco Co Inc
  226. Histogen
  227. Hoth Therapeutics
  228. Humanigen Inc
  229. Hut 8 Mining Corp
  230. Hycroft Mining Holding Corporation
  231. Hyperfine
  232. HyreCar Inc
  233. Hyzon Motors
  234. I-Mab
  235. IM Cannabis Corp
  236. IN8BIO
  237. INVO Bioscience
  238. IO Biotech
  239. IT Tech Packaging Inc
  240. Ideanomics Inc
  241. Imac Holdings Inc
  242. Immix Biopharma
  243. Immutep Ltd
  244. Imperalis Holding Corp.
  245. InMed Pharmaceuticals
  246. India Globalization Capital
  247. Inhibikase Therapeutics
  248. Innovative Eyewear Inc
  249. Inseego
  250. Instil Bio
  251. Intelligent Bio Solutions Inc
  252. Invitae Corp
  253. IonQ
  254. Iveda Solutions Inc
  255. Jaguar Health
  256. KULR Technology Group
  257. Kala Pharmaceuticals
  258. Kartoon Studios Inc
  259. Karyopharm Therapeutics
  260. Kidpik Corp
  261. Kineta Inc
  262. Kintara Therapeutics
  263. Kiora Pharmaceuticals
  264. Knightscope
  265. Know Labs Inc
  266. LM Funding America
  267. LQR House Inc
  268. Laser Photonics Corp
  269. Leafly Holdings
  270. Lexicon Pharmaceuticals
  271. Liberty TripAdvisor Hlds
  272. Lightning eMotors Inc
  273. Lion Electric
  274. Lipocine
  275. LiqTech International
  276. LiveWire Group Inc
  277. Local Bounti Corp
  278. Longeveron
  279. Lottery.com
  280. Lucy Scientific Discovery Inc
  281. Lufax Holding
  282. MAIA Biotechnology Inc
  283. MEI Pharma
  284. MSP Recovery Inc
  285. Mangoceuticals Inc
  286. Marker Therapeutics Inc
  287. Marpai
  288. Matinas BioPharma Hlds
  289. MedAvail Holdings Inc
  290. Medicenna Therapeutics Corp
  291. Medigus Ltd Sponsored
  292. Mega Matrix Corp
  293. Mereo Biopharma Group Plc - ADR
  294. Mersana Therapeutics
  295. Mesoblast
  296. Meta Data Ltd
  297. Meta Materials
  298. MicroVision
  299. Micromobility.com Inc
  300. Milestone Pharmaceuticals Inc
  301. Milestone Scientific
  302. Mind Medicine MindMed
  303. Minerva Surgical
  304. Minim
  305. Missfresh Ltd
  306. Mobile Global Esports Inc
  307. Mobiquity Technologies
  308. Mogo
  309. Moleculin Biotech
  310. Motus GI Hlds
  311. Mountain Crest Acquisition Corp II
  312. Mullen Automotive
  313. My Size
  314. MyMD Pharmaceuticals
  315. Myomo
  316. NIKE
  317. NIO
  318. NRX Pharmaceuticals
  319. NanoVibronix
  320. NanoViricides
  321. Navidea Biopharma
  322. Nektar Therapeutics
  323. NeoVolta Inc
  324. Neptune Wellness Solutions Inc
  325. NeuBase Therapeutics Inc
  326. NeuroBo Pharmaceuticals Inc
  327. NeuroOne Medical Technologies Corp
  328. Neuronetics Inc
  329. NexImmune
  330. Nexgel
  331. NextPlay Technologies
  332. Nkarta, Inc.
  333. Nocera Inc
  334. Nogin Inc
  335. NovaBay Pharmaceuticals
  336. Novan Inc
  337. Novo Integrated Sciences, Inc.
  338. NuCana
  339. Nuburu Inc
  340. Nuuve
  341. Nxu Inc
  342. Oblong
  343. Ocugen, Inc.
  344. Olo
  345. OncoCyte
  346. Onconova Therapeutics
  347. Ontrak
  348. OpGen
  349. Opendoor
  350. Oragenics
  351. OrganiGram Holdings Inc.
  352. Origin Materials
  353. Owlet
  354. Palatin Technologies
  355. Palisade Bio
  356. Panbela Therapeutics Inc
  357. Paramount Gold Nevada
  358. PaxMedica Inc
  359. PayPal
  360. Pear Therapeutics Inc
  361. Polished.com Inc
  362. Quince Therapeutics Inc
  363. RiskOn International Inc
  364. Ryvyl Inc
  365. Scorpius Holdings Inc
  366. Soluna Holdings, Inc.
  367. Spyre Therapeutics Inc
  368. Talphera Inc
  369. Tharimmune Inc
  370. The Oncology Institute
  371. TurnOnGreen Inc
  372. WaveDancer
  373. aTyr Pharma
  374. bioAffinity Technologies Inc
  375. bluebird bio
  376. cbdMD Inc
  377. eFFECTOR Therapeutics Inc
  378. iCAD
  379. iMedia Brands Inc
  380. iShares Core U.S. Aggregate Bond ETF
  381. iShares Self-Driving EV and Tech ETF
  382. mCloud Technologies Corp
  1. Asset
    Price
  2. ANGI Homeservices
  3. ATI Physical Therapy
  4. Advanced Health Intelligence
  5. Advent Technologies Holdings
  6. Affimed
  7. Airspan Networks Holdings Inc
  8. Altria

All of your investing.
All in one place.

Invest in stocks, treasuries, ETFs, crypto, and alternative assets on Public. Transfer your account to Public and get up to $10,000.
Sign Up
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2024 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Product offerings and availability vary based on jurisdiction.

Stocks, ETFs, Options, Bonds.
Self-directed brokerage accounts and brokerage services for US-listed, registered securities, options, and Bonds, except for treasury securities offered through Jiko Securities, Inc., are offered to self-directed customers by Open to the Public Investing, Inc. (“Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Public Investing is not registered. Securities products offered by Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here.

Options.
Certain requirements must be met in order to trade options. Options can be risky and are not suitable for all investors. Options transactions are often complex, and investors can rapidly lose the entire amount of their investment or more in a short period of time. Investors should consider their investment objectives and risks carefully before investing in options. Refer to the Characteristics and Risks of Standardized Options before considering any options transaction. Supporting documentation for any claims, if applicable, will be furnished upon request. Tax considerations with options transactions are unique and investors considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.

Options Order Flow Rebate.
If you are enrolled in our Options Order Flow Rebate Program, Public Investing will share 50% of our estimated order flow revenue for each completed options trade as a rebate to help reduce your trading costs. The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions.

Bonds.
“Bonds” shall refer to corporate debt securities and U.S. government securities offered on the Public platform through a self-directed brokerage account held at Public Investing and custodied at Apex Clearing. For purposes of this section, Bonds exclude treasury securities held in treasury accounts with Jiko Securities, Inc. as explained under the “ Treasury Accounts” section.

Investments in Bonds are subject to various risks including risks related to interest rates, credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. The value of Bonds fluctuate and any investments sold prior to maturity may result in gain or loss of principal. In general, when interest rates go up, Bond prices typically drop, and vice versa. Bonds with higher yields or offered by issuers with lower credit ratings generally carry a higher degree of risk. All fixed income securities are subject to price change and availability, and yield is subject to change. Bond ratings, if provided, are third party opinions on the overall bond's credit worthiness at the time the rating is assigned. Ratings are not recommendations to purchase, hold, or sell securities, and they do not address the market value of securities or their suitability for investment purposes.

High-Yield Cash Account.
A High-Yield Cash Account is a secondary brokerage account with Public Investing. Funds in your High-Yield Cash Account are automatically deposited into partner banks (“Partner Banks”), where that cash earns interest and is eligible for FDIC insurance. See here for a list of current Partner Banks. Your Annual Percentage Yield is variable and may change at the discretion of the Partner Banks or Public Investing. Apex Clearing and Public Investing receive administrative fees for operating this program, which reduce the amount of interest paid on swept cash. Neither Public Investing nor any of its affiliates is a bank. Learn more.

Alternative Assets.
Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in a Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public Investing, and Public Investing (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency.
Cryptocurrency trading, execution, and custody services are provided by Bakkt Crypto Solutions, LLC (NMLS ID 1828849) (“Bakkt”). Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrencies offered by Bakkt are not securities and are not FDIC insured or protected by SIPC. Your cryptocurrency assets are held in your Bakkt account. Bakkt is a licensed virtual currency business by the New York State Department of Financial Services and a licensed money transmitter, but is not a registered broker-dealer or a FINRA member. Your Bakkt Crypto account is separate from your brokerage account with Public Investing, which holds US-listed stocks and ETFs. Please review the Risk Disclosures before trading.

Treasury Accounts.
Investing services in treasury accounts offering 6 month US Treasury Bills on the Public platform are through Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information.

JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). T-bills are purchased at a discount to the par value and the T-bill’s yield represents the difference in price between the “par value” and the “discount price.” Aggregate funds in your Treasury Account in excess of the T-bill purchases will remain in your Treasury Account as cash. The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability - yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates. Although T-bills are considered safer than many other financial instruments, you could lose all or a part of your investment. See Jiko U.S. Treasuries Risk Disclosures for further details.

Investments in T-bills: Not FDIC Insured; No Bank Guarantee; May Lose Value.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Commission-free trading refers to $0 commissions charged on trades of US listed registered securities placed during the US Markets Regular Trading Hours in self-directed brokerage accounts offered by Public Investing. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Public’s Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

Investment Plans. US members only. Investment Plans (“Plans”) shown in our marketplace are for informational purposes only and are meant as helpful starting points as you discover, research and create a Plan that meets your specific investing needs. Plans are self-directed purchases of individually-selected assets, which may include stocks, ETFs and cryptocurrency. Plans are not recommendations of a Plan overall or its individual holdings or default allocations. Plans are created using defined, objective criteria based on generally accepted investment theory; they are not based on your needs or risk profile. You are responsible for establishing and maintaining allocations among assets within your Plan. Plans involve continuous investments, regardless of market conditions. Diversification does not eliminate risk. See our Investment Plans Terms and Conditions and Sponsored Content and Conflicts of Interest Disclosure.

Market Data. Quotes and other market data for Public’s product offerings are obtained from third party sources believed to be reliable, but Public makes no representation or warranty regarding the quality, accuracy, timeliness, and/or completeness of this information. Such information is time sensitive and subject to change based on market conditions and other factors. You assume full responsibility for any trading decisions you make based upon the market data provided, and Public is not liable for any loss caused directly or indirectly by your use of such information. Market data is provided solely for informational and/or educational purposes only. It is not intended as a recommendation and does not represent a solicitation or an offer to buy or sell any particular security.